178 related articles for article (PubMed ID: 35566290)
1. Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs.
Li M; Su F; Zhu M; Zhang H; Wei Y; Zhao Y; Li J; Lv S
Molecules; 2022 May; 27(9):. PubMed ID: 35566290
[TBL] [Abstract][Full Text] [Related]
2. [Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].
Wang YY; Zhang XJ; Yang YR; Sun HP; You QD
Yao Xue Xue Bao; 2014 Mar; 49(3):293-302. PubMed ID: 24961098
[TBL] [Abstract][Full Text] [Related]
3. Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents.
Wang J; Ma J; You Q; Zhao L; Wang F; Li C; Guo Q
Eur J Med Chem; 2010 Sep; 45(9):4343-53. PubMed ID: 20605273
[TBL] [Abstract][Full Text] [Related]
4. Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Wu Y; Hu M; Yang L; Li X; Bian J; Jiang F; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Jun; 25(12):2584-8. PubMed ID: 25958244
[TBL] [Abstract][Full Text] [Related]
5. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
Li X; Wu Y; Wang Y; You Q; Zhang X
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
[No Abstract] [Full Text] [Related]
6. Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG₂₀₀₀ micelles.
Cai L; Qiu N; Xiang M; Tong R; Yan J; He L; Shi J; Chen T; Wen J; Wang W; Chen L
Int J Nanomedicine; 2014; 9():243-55. PubMed ID: 24403830
[TBL] [Abstract][Full Text] [Related]
7. Studies on chemical-structure modification and structure-activity relationship of gambogic acid derivatives at carbon(34).
Zhang XJ; Li X; Yang YR; Sun HP; Gao Y; Zhang L; Wang JX; Guo QL; You QD
Chem Biodivers; 2012 Oct; 9(10):2295-308. PubMed ID: 23081928
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Highly Potent and Novel Gambogic Acid Derivative as an Anticancer Drug Candidate.
Ling H; Li H; Chen M; Lai B; Zhou H; Gao H; Zhang J; Huang Y; Tao Y
Anticancer Agents Med Chem; 2021; 21(9):1110-1119. PubMed ID: 32268871
[TBL] [Abstract][Full Text] [Related]
9. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay.
Zhang HZ; Kasibhatla S; Wang Y; Herich J; Guastella J; Tseng B; Drewe J; Cai SX
Bioorg Med Chem; 2004 Jan; 12(2):309-17. PubMed ID: 14723951
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
[TBL] [Abstract][Full Text] [Related]
11. Improved druggability of gambogic acid using core-shell nanoparticles.
Liu F; Huang X; Han L; Sang M; Hu L; Liu B; Duan B; Jiang P; Wang X; Qiao Z; Ma C; Liu W; Liu J; Feng F; Qu W
Biomater Sci; 2019 Feb; 7(3):1028-1042. PubMed ID: 30608065
[TBL] [Abstract][Full Text] [Related]
12. A solvent-assisted active loading technology to prepare gambogic acid and all-trans retinoic acid co-encapsulated liposomes for synergistic anticancer therapy.
Na K; Liu K; Yu J; Wang X; Li M; Tian C; He H; He Y; Wang Y
Drug Deliv Transl Res; 2020 Feb; 10(1):146-158. PubMed ID: 31529371
[TBL] [Abstract][Full Text] [Related]
13. Stability and cytotoxicity of gambogic acid and its derivative, gambogoic acid.
Han QB; Cheung S; Tai J; Qiao CF; Song JZ; Xu HX
Biol Pharm Bull; 2005 Dec; 28(12):2335-7. PubMed ID: 16327177
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer.
Zhang D; Chu Y; Qian H; Qian L; Shao J; Xu Q; Yu L; Li R; Zhang Q; Wu F; Liu B; Liu Q
Int J Nanomedicine; 2020; 15():735-747. PubMed ID: 32099362
[TBL] [Abstract][Full Text] [Related]
15. Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39).
Sun HP; Liu ZL; Xue X; Gao Y; Zhang L; Wang JX; Guo QL; You QD
Chem Biodivers; 2012 Aug; 9(8):1579-90. PubMed ID: 22899618
[TBL] [Abstract][Full Text] [Related]
16. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
[TBL] [Abstract][Full Text] [Related]
17. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
18. Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid.
Wang J; Zhao L; Hu Y; Guo Q; Zhang L; Wang X; Li N; You Q
Eur J Med Chem; 2009 Jun; 44(6):2611-20. PubMed ID: 18996626
[TBL] [Abstract][Full Text] [Related]
19. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.
Doddapaneni R; Patel K; Owaid IH; Singh M
Drug Deliv; 2016 May; 23(4):1232-41. PubMed ID: 26701717
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
